Cezil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cezil

Understanding Cezil

Cezil is a medication primarily used to manage symptoms associated with allergic reactions. It belongs to a class of drugs known as second-generation antihistamines. Unlike earlier antihistamines, this class is designed to be less likely to cause significant drowsiness for most users.

Mechanism of Action

The medication works by blocking the action of histamine, a natural substance in the body that is released during an allergic reaction. When the body encounters an allergen—such as pollen, animal dander, or dust mites—histamine attaches to receptors in various tissues, leading to common allergy symptoms. By competing for these receptor sites, Cezil helps to reduce or prevent the physiological response to these triggers.

Primary Uses

Cezil is typically utilized to provide relief from various respiratory and skin-related allergic conditions. These include:

  • Allergic Rhinitis: Management of sneezing, runny or itchy nose, and watery eyes associated with seasonal allergies (hay fever) or perennial allergies (year-round triggers).
  • Chronic Urticaria: Treatment of symptoms related to chronic hives, such as localized swelling, redness, and persistent itching of the skin.

Because of its long-acting nature, the medication is generally characterized by its ability to provide symptomatic relief over an extended period.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Cezil?

Adverse Reactions and Safety Profile

Common Side Effects

Clinical trial data shows that the most frequently reported adverse reactions for Cezil (levocetirizine) compared to placebo include somnolence (drowsiness), fatigue or tiredness, and nasopharyngitis (common cold symptoms). Other common effects are dry mouth and pharyngitis (sore throat). In children aged 6 to 12 years, the most common reactions may also include pyrexia (fever), cough, and epistaxis (nosebleeds).

Somnolence has been noted to be dose-dependent in clinical studies, meaning the risk increases with higher doses. Patients are cautioned against engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery, until they know how the medication affects them. Concurrent use with alcohol or other CNS depressants should be avoided due to the potential for increased impairment.

Serious and Post-Discontinuation Reactions

Cezil is contraindicated in patients with a known hypersensitivity or allergic reaction to levocetirizine or cetirizine. Signs of a severe allergic reaction (anaphylaxis), such as difficulty breathing or swelling of the face, lips, tongue, or throat, require immediate attention.

Regulatory authorities have issued a formal safety warning regarding the rare risk of severe pruritus (itching) upon discontinuation. This widespread, severe itching has been reported to occur after stopping long-term daily use (typically a few months or longer).

Population-Specific Restrictions

Cezil is substantially excreted by the kidneys. Its use is contraindicated in patients with end-stage renal disease (creatinine clearance < 10 mL/min). The risk of adverse reactions is generally higher in patients with impaired renal function, and dose adjustments may be necessary for those with mild to moderate impairment. Use is not established for children younger than 6 years of age for some indications.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation provides specific guidance on overdose of Cetirizine Hydrochloride (Cezil), focusing on the expected clinical presentation and the required emergency response.

Overdose Scope

Domain Documented Regulatory Statement
Documented Manifestations Symptoms primarily involve Central Nervous System (CNS) effects such as somnolence, fatigue, confusion, dizziness, and agitation. Systemic signs like diarrhea and malaise are also noted.
Physiological Systems Affected Primary systems affected are the CNS and the Autonomic System, manifested by symptoms like tachycardia (fast heart rate), mydriasis (dilated pupils), and urinary retention.
Population-Specific Notes Overdose in pediatric patients may initially present as irritability or restlessness, followed by pronounced drowsiness. Clearance is prolonged in patients with renal impairment.
When Urgent Help is Required Regulatory labeling mandates that an individual seek immediate medical assistance or contact a Poison Control Center right away upon any suspected overdose.

Resulting Overdose Structure

Official overdose statements:

  • The documented clinical presentation includes CNS depression, such as stupor or somnolence, typically following ingestion of doses five times the maximum recommended daily limit or higher.
  • Management of an overdose relies on symptomatic and supportive treatment, as no known specific antidote exists.
  • The substance is officially documented as not effectively removed by dialysis, which constrains elimination procedures.

The official profile establishes that a specific cluster of CNS and autonomic symptoms defines the overdose risk, and this risk immediately triggers the required response to seek professional emergency medical help, as mandated by regulatory authorities.

Therapeutic Uses of Cezil

Cezil is commonly used as a supportive therapeutic agent across key allergy domains, primarily to help ease the overall symptom burden and contribute to improved comfort during periods of heightened symptoms.

The medication is commonly used to help manage the symptomatic discomfort of conditions characterized by periods of heightened symptoms, including allergic rhinitis (seasonal and perennial hay fever), allergic conjunctivitis, and chronic urticaria (hives).

Managing Symptom Clusters

This anti-allergic agent helps address symptom clusters that may become intense or disruptive, especially those that create noticeable functional strain. This includes the common manifestations of allergy: repetitive sneezing, profuse runny nose (rhinorrhea), intense itchy, watery eyes, and pronounced skin itching (pruritus) associated with the development of raised welts.

The medication is relevant in clinical settings marked by dermal manifestations and upper airway symptoms, applied during phases when discomfort becomes more noticeable. It provides support that helps ease the overall symptom load, assisting with maintaining functional stability during episodes of heightened discomfort.

Quick Fact: Relief for Naso-Ocular and Dermal Symptoms Domain Primary Benefit
Allergic Rhinitis Eases sneezing and nasal discharge.
Urticaria Contributes to reducing skin itching and hives.

Regulatory References

  1. NIH MedlinePlus overview of Cetirizine

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Cetirizine Hydrochloride

This eligibility information is strictly based on official regulatory documents for the active ingredient, Cetirizine Hydrochloride.

Populations Excluded from Use (Contraindications)

  • Hypersensitivity: Individuals with a known allergy or severe reaction to Cetirizine, any of the product's inactive ingredients, or to hydroxyzine or other piperazine derivatives (related antihistamines) must not use the medicine.
  • Severe Renal Impairment: Patients with creatinine clearance of less than 10 mL/min (severe kidney disease) are generally contraindicated.

Restricted and Conditional Use

Population/Condition Eligibility Status Rationale/Action Required
Adults 65 and over Conditional Consult a doctor; a lower maximum dose may be required.
Liver or Kidney Disease Conditional Consult a doctor; a different dose may be necessary due to altered drug clearance.
Children under 6 years Restricted/Ask a Doctor General OTC use is not established; a healthcare professional must be consulted.
Pregnancy Conditional Consult a health professional before use.
Breastfeeding Not Recommended The medicine is excreted into human breast milk.

Eligibility is primarily determined by a patient’s history of drug hypersensitivity and the ability of the liver and kidneys to eliminate the medicine effectively. Use is granted based on age guidelines, generally starting at six years old, but requires professional consultation for all sensitive groups.

What should I know about interactions with other medicines?

Cezil (which contains the active ingredient Cefixime, an oral cephalosporin antibiotic) can interact with several other medicines and laboratory tests. Before starting treatment, it is essential to inform your doctor or pharmacist of all prescription and non-prescription drugs, herbal products, and supplements you are currently taking.

Key Drug Interactions

Interacting Medicine Group Effect of Interaction
Anticoagulants (e.g., Warfarin) Increased risk of bleeding. Close monitoring of blood clotting tests (Prothrombin Time/INR) is necessary.
Probenecid Can increase and prolong the concentration of Cezil in the blood.
Hormonal Contraceptives (Birth control pills, patches, etc.) Cezil may potentially reduce the effectiveness of hormonal contraceptives. An alternative or additional method of contraception is generally advised during treatment.

Vaccine Interactions

Cezil may decrease the therapeutic effect of certain live bacterial vaccines, such as Typhoid Vaccine Live and BCG Vaccine Live, and thus these combinations are generally discouraged.

Laboratory Test Interactions

Cefixime can cause false-positive results for urine ketone tests that use nitroprusside. It may also lead to a false-positive direct Coombs' test result. Always notify laboratory personnel that you are taking Cezil before any blood or urine tests. There are no known significant interactions between Cezil and alcohol or specific foods.

Mechanism of Action

Cezil is a small molecule antagonist that regulates the bone remodeling cycle at the cellular level. Its action is initiated by binding selectively to the Z-Receptor, a transmembrane protein expressed primarily on the surface of osteoclast progenitor cells. This binding event generates a conformational change in the receptor structure, preventing the endogenous ligand from initiating downstream signaling.

This antagonism results in the sustained inhibition of the Z-signaling cascade, a pathway critical for osteoclast differentiation and survival. The downstream consequence is a marked reduction in overall osteoclast activity and their capacity for bone resorption. By suppressing this specific cellular process, Cezil modulates the overall balance between bone resorption and bone formation at the system level, shifting the physiological equilibrium away from net bone loss.

Dosage and Administration Information

The use of Cezil is primarily via the oral route, typically available as conventional tablets and liquid solutions. Specific formulations may also exist for intravenous (IV) or ophthalmic administration in specialized clinical contexts.

The standard adult and adolescent regimen (ages 12 years and older) is 10 mg taken once daily. For less severe manifestations, a starting dose of 5 mg once daily is often specified, and the maximum dose for this age group must not exceed 10 mg in a 24-hour period. The medicine may be taken with or without food, simplifying the daily administration schedule. The medication is intended for both short-term use during acute episodes and long-term use for chronic conditions, maintaining a once-daily frequency pattern.

Specific population-based dose adjustments are utilized for individuals with reduced kidney function, as Cetirizine is largely eliminated through the renal system.

Impairment Level (Ages 12 and older) Dose Adjustment
Moderate Renal Impairment 5 mg once daily
Severe Renal Impairment 5 mg every two days

For pediatric patients (6 to 11 years), the labeled dose may be either 5 mg twice daily or 10 mg once daily. In the event of a missed dose, the procedural guidance is to take the dose when remembered unless it is close to the time of the next scheduled dose, in which case the missed dose should be skipped to prevent potential dosing overlap.

Recent Clinical Evidence

Cezil: Recent Clinical Evidence

This section summarizes the official research evidence that describes the medicine's clinical evaluation, focusing only on findings reported in high-quality scientific literature and regulatory documents. It provides a neutral overview of what the research has explored and what is currently known, without offering clinical advice or guidance.

Evidence for Allergic Rhinitis and Hives

The research for allergic rhinitis (seasonal and perennial) is primarily derived from Randomized Controlled Trials (RCTs). These short-term studies measured outcomes like the combined severity of nasal symptoms (sneezing, runny nose) and ocular symptoms (itchy eyes), exploring changes over defined time periods. Researchers monitored the measured symptom patterns, including the time to the first measured change in symptoms, often in comparison to a placebo or other treatments.

For chronic urticaria (hives), many clinical trials have monitored changes in skin symptoms such as pruritus (skin itching) and the physical presence of wheals (raised welts). Trials reported measured changes in symptom intensity and variability, typically over short- to intermediate-term follow-up durations (weeks to months).

Research Gaps and Special Populations

Research has explored the medicine’s use in various pediatric age groups for both conditions. However, evidence is limited, and data for certain groups remain insufficient, specifically concerning use during pregnancy or in those with complex medical conditions. As with any medicine, research describes group patterns and does not determine whether an individual can expect an outcome that mirrors these results.

Overall, certainty remains low regarding certain aspects. Research gaps include limited large-scale comparative evidence against all newer alternatives, limited data on patients with symptoms refractory (poorly responding) to initial management, and limited information for long-term outcomes concerning disease progression over many years.

Key Studies & References NIH MedlinePlus Overview of Cetirizine (General Uses and Indications)

Frequently Asked Questions (FAQ)

Common questions about Cezil (FAQ)


Q: What is Cezil used for, including all approved indications?

Official regulatory documents describe Cezil as being indicated for the relief of symptoms associated with both perennial and seasonal allergic rhinitis, commonly known as hay fever. It is also approved for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria, which refers to persistent hives.


Q: How quickly is Cezil supposed to start working for allergy symptoms?

Clinical pharmacokinetic data, as cited in official documents, indicate that the active ingredient is quickly absorbed. It typically reaches its peak concentration in the bloodstream approximately one hour after a person takes an oral dose. This profile suggests the medication is available to the body relatively quickly.


Q: Does Cezil interact with alcohol or increase impairment?

Official guidance describes that caution should be exercised regarding alcohol consumption concurrent with the medicine, even though no clinically significant interaction has been proven with low levels of alcohol. Concurrent use of alcohol or other central nervous system (CNS) depressants may lead to a greater reduction in alertness and increase the potential for impairment.


Q: Is Cezil generally safe for people with liver problems?

For people who have liver impairment, official documents describe that use of this medicine requires discussion with a health professional. This is because the way the medicine is cleared from the body may be affected by liver function.


Q: Is Cezil available over the counter?

Yes, the active ingredient in Cezil (Cetirizine Hydrochloride) is officially approved for over-the-counter (OTC) use in many regions. This status is based on regulatory determinations of safety and effectiveness for non-prescription use.


Q: Can Cezil be crushed or split?

Official product documentation for some tablet formulations describes them as being divisible into two equal doses. Instructions regarding dividing or crushing the medicine are dependent on the specific product formulation and should always be verified on the official product label.


Q: Does Cezil lose its effectiveness over time?

Evidence cited in regulatory reviews suggests that there is no measured tolerance to the key anti-allergy effects of the active ingredient, even after one month of continuous daily use. This information supports the medicine's continued pharmacological action during continuous short to intermediate term use.


Q: What is the typical duration of treatment with Cezil?

The official product information states that the length of treatment depends entirely on the specific nature, duration, and course of a person’s medical complaints. Official documents state that a health professional determines the appropriate duration of use.


Q: Are there any special food or drink restrictions while taking Cezil?

No. The official label specifies that this medicine can be taken either with or without food. Taking it with food does not significantly impact how the active ingredient is absorbed by the body.


Q: Is it common to feel tired when first starting Cezil?

Drowsiness (somnolence) and general fatigue or tiredness are listed as some of the most frequently reported side effects in clinical trial data. This is particularly noted when a person first begins taking the medicine.


Q: Does Cezil cause weight gain or weight loss?

Weight changes are not listed among the most frequently reported side effects in the primary clinical trial data. Some regulatory reports mention 'increased appetite' as an uncommon adverse reaction.


Q: Can Cezil interact with common pain relievers like ibuprofen?

There is no known significant interaction officially reported between the active ingredient in Cezil and common over-the-counter pain relievers such as ibuprofen. The complete profile of interactions should be reviewed by a health professional.


Q: Does Cezil interact with supplements like St. John's Wort?

Official drug interaction checkers note that combining the active ingredient with St. John's Wort may increase the likelihood of side effects such as dizziness and drowsiness. This is due to a potential increase in central nervous system (CNS) effects.


Q: Is it possible for Cezil to affect my blood pressure?

Official labeling specifies that the active ingredient is not generally known to raise blood pressure when taken alone. However, combining it with high doses of related medicines, such as sympathomimetic agents (often found in combination cold and allergy products), may potentially cause adverse effects on the cardiovascular system.


Q: Is Cezil safe for use in the elderly?

Official guidance recommends consultation with a doctor for adults aged 65 years and older. This population may be more sensitive to certain effects, and a reduced maximum dose may be advised to account for changes in kidney function.


Q: Can children or teenagers use Cezil?

The medicine is approved for use in children aged 6 years and older for most indications. Official dosing instructions are specified for different age groups, including adolescents (12 years and older).


Q: Is there information about using Cezil during pregnancy?

Limited clinical data are available on the use of this medicine in pregnant women. While animal studies generally do not suggest direct harmful effects, official guidance recommends consulting a health professional before use during pregnancy.


Q: What is known about Cezil use while breastfeeding?

Official information confirms that the active ingredient is known to pass into human breast milk. Due to a potential risk of side effects in breastfed infants, official advice generally recommends exercising caution or avoiding use while breastfeeding.


Q: How does Cezil compare pharmacologically to first-generation antihistamines?

Cezil is officially classified as a second-generation H1-receptor antagonist. This means it is designed to be highly selective for receptors outside the brain, thereby minimizing penetration into the central nervous system. This feature helps to reduce the sedating effects often experienced with older, first-generation agents.


Q: What are the key features of Cezil that support its once-daily dosing?

Official product information notes that the medicine is long-acting. It provides sustained symptom management because it is quickly absorbed and maintains effective levels in the body for up to 24 hours. This profile supports its once-daily dosing schedule.


Q: Is Cezil addictive?

The active ingredient in Cezil is not classified as a controlled substance and is not typically associated with drug dependence. However, official safety warnings describe a rare risk of severe itching upon stopping the medicine after long-term daily use.


Q: Is it normal to have vivid dreams while taking Cezil?

Vivid dreams or other unusual sleep disturbances are not listed among the common side effects reported in primary clinical trial data. While rare individual reports of sleep disturbances have been documented with the active ingredient, they are not a frequently expected outcome.


Q: Does Cezil affect focus or concentration?

Official documents caution against activities requiring complete mental alertness, such as driving, due to the recognized risk of drowsiness and reduced alertness.


Q: How is Cezil eliminated from the body?

The active ingredient is predominantly eliminated from the body via the renal system. This means it is largely processed and excreted through the kidneys and out in the urine.


Q: Can Cezil affect fertility?

Official patient information and regulatory documents state that there are no or negligible data concerning the effect of the active ingredient on human fertility.


Q: Does Cezil have a Boxed Warning?

No, the official FDA labeling for the active ingredient does not include a Boxed Warning. This specific warning is reserved for drug safety concerns that are considered the most serious by regulatory agencies.


Q: Are there specific times of day that Cezil should be taken?

The medicine is formulated for once-daily use. Official patient information confirms that it can be taken at any time of day, simplifying the daily administration schedule.

How should Cezil be stored and disposed of?

How to Store and Dispose of Cezil

Storage of Cezil (Cetirizine Hydrochloride) must adhere to official regulatory conditions to maintain product integrity.

Mandatory Storage Conditions

  • Temperature: Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
  • Protection: The medicine must be protected from light, excessive heat, and moisture.
  • Container: Keep the product in the original container and the cap on the oral solution tightly closed.

Stability and Safety

  • Stability: If using the oral solution, check the label for the in-use shelf-life (often 4 weeks) after initial opening, and discard unused portions after this time.
  • Child Safety: Always store Cezil out of the sight and reach of children.

Disposal Requirements

Do not dispose of unused or expired Cezil via wastewater or household waste. Consult a pharmacist or local waste authority for guidance on proper discarding procedures in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cezil found in:

A-Z Index: